Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice - PubMed (original) (raw)

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice

M L'hirondel et al. Brain Res. 1998.

Abstract

Mouse purified striatal synaptosomes were used to study the release of newly synthesised [3H]-dopamine ([3H]-DA) or of previously taken up [3H]-DA. Quinpirole (QP, 10 microM), a D2/D3 dopaminergic agonist, was found to reduce the release of newly synthesised [3H]-DA with a larger amplitude when 4-aminopyridine (100 microM) instead than veratridine (1 microM) or potassium (25 mM) was used to evoke DA release. Among the different D2/D3 dopaminergic agonists tested R(-)-propylnorapomorphine (NPA) and quinpirole were the most potent. These compounds reduced, in a concentration-dependent manner, the 4-aminopyridine-evoked release of [3H]-DA previously taken up by synaptosomes (50% maximal inhibition). In contrast, the D3 agonist PD-128,907 had little effect even when used at 100 nM. The QP (100 nM)-induced response was completely antagonised by sulpiride (1 microM). Strikingly, the NPA (100 nM) and PD-128,907 (100 nM)-evoked responses were completely suppressed in D2 receptor-deficient mice. This data strongly suggest that only D2 but not D3 receptors are involved in the autoreceptor-mediated inhibition of the evoked release of [3H]-DA. Interestingly, while amphetamine-induced release of [3H]-DA was not modified, a slight reduction of [3H]-DA efflux induced by the dopamine (DA) uptake inhibitor cocaine was observed in D2 receptor-deficient mice.

PubMed Disclaimer

Cited by

GPA-14, a Gα(i) subunit mediates dopaminergic behavioral plasticity in C. elegans.
Mersha M, Formisano R, McDonald R, Pandey P, Tavernarakis N, Harbinder S. Mersha M, et al. Behav Brain Funct. 2013 Apr 22;9:16. doi: 10.1186/1744-9081-9-16. Behav Brain Funct. 2013. PMID: 23607404 Free PMC article.
Dopamine receptor signaling and current and future antipsychotic drugs.
Boyd KN, Mailman RB. Boyd KN, et al. Handb Exp Pharmacol. 2012;(212):53-86. doi: 10.1007/978-3-642-25761-2_3. Handb Exp Pharmacol. 2012. PMID: 23129328 Free PMC article. Review.
Synaptosomes still viable after 25 years of superfusion.
Raiteri L, Raiteri M. Raiteri L, et al. Neurochem Res. 2000 Oct;25(9-10):1265-74. doi: 10.1023/a:1007648229795. Neurochem Res. 2000. PMID: 11059801 Review.
Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
Chauhan H, Killinger BA, Miller CV, Moszczynska A. Chauhan H, et al. Int J Mol Sci. 2014 Apr 8;15(4):5884-906. doi: 10.3390/ijms15045884. Int J Mol Sci. 2014. PMID: 24717411 Free PMC article.
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons.
Jiang H, Xu Z, Zhong P, Ren Y, Liang G, Schilling HA, Hu Z, Zhang Y, Wang X, Chen S, Yan Z, Feng J. Jiang H, et al. Nat Commun. 2015 Dec 7;6:10100. doi: 10.1038/ncomms10100. Nat Commun. 2015. PMID: 26639555 Free PMC article.

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice - PubMed (original) (raw)